Abstract
Stem cells, as classically defined, are cells with a capacity to self-renew and to generate daughter cells that can differentiate down several cell lineages to form all of the cell types that are found in the mature tissue. Stem cells and tumour cells have many similar features, including infinite lifespan, self-renewal, multidrug resistance, telomerase expression and, in the instance of the prostate, androgen independence. Evidence supports a role for stem cells in the etiology of many types of cancer. The evolution of androgen-independent prostate carcinoma may reflect the emergence of stemlike prostate tumour cells. Because cancer may be a disease of stem cell lineages and Shh-Gli signalling controls the behaviour of precursors and of cells with stem cell properties in the mammalian tissues, prostate cancer might derive from inappropriate expansion of prostatic epithelial stem cell lineages caused by abnormal Shh-Gli function. This review attempts to integrate these recent results.
Similar content being viewed by others
Author information
Authors and Affiliations
Corresponding author
Additional information
*Supported by an unrestricted educational grant from Sanofi-Aventis.
Rights and permissions
About this article
Cite this article
Antón Aparicio, L.M., Cassinello Espinosa, J., García Campelo, R. et al. Prostate carcinoma and stem cells. Clin Transl Oncol 9, 66–76 (2007). https://doi.org/10.1007/s12094-007-0015-6
Issue Date:
DOI: https://doi.org/10.1007/s12094-007-0015-6